鈴木岳之

スズキタケシ | Takeshi Suzuki

所属機関・部署：
職名：教授
競争的資金等の研究課題 (1件)：

論文 (94件)：

Tamura F, Sugimoto S, Sugimoto M, Sakamoto K, Yamaguchi M, Suzuki T, Fukuda K, Ieda M, Kurokawa J. The effect of a synthetic estrogen, ethinylestradiol, on the herg block by e-4031. Biomolecules. 2021. 11. 9
Yoshimoto A, Yamashiro K, Suzuki T, Ikegaya Y, Matsumoto N. Ramelteon modulates gamma oscillations in the rat primary motor cortex during non-REM sleep. Journal of Pharmacological Sciences. 2021. 145. 1. 97-104
Kurotsu S, Sadahiro T, Fujita R, Tani H, Yamakawa H, Tamura F, Isomi M, Kojima H, Yamada Y, Abe Y, et al. Soft Matrix Promotes Cardiac Reprogramming via Inhibition of YAP/TAZ and Suppression of Fibroblast Signatures. Stem Cell Reports. 2020. 15. 3. 612-628
Shibata S, Fukumoto D, Suzuki T, Ozaki K. A Comparative Study of the Market Configuration of the Japanese Pharmaceutical Market Using the Gini Coefficient and Herfindahl-Hirschman Index. Therapeutic Innovation and Regulatory Science. 2020. 54. 5. 1047-1055
Higashikuse Y, Mittal N, Arimura T, Yoon S.H, Oda M, Enomoto H, Kaneda R, Hattori F, Suzuki T, Kawakami A, et al. Perturbation of the titin/MURF1 signaling complex is associated with hypertrophic cardiomyopathy in a fish model and in human patients. DMM Disease Models and Mechanisms. 2019. 12. 11

MISC (1件)：

書籍 (6件)：

講演・口頭発表等 (51件)：

Neural differentiation potentials in human embryonic stem cell lines.
(第87回日本薬理学会年会 2014)
抗うつ薬とP2X4受容体の相互作用の比較検討.
(日本薬学会第134回年会 2014)
新薬創出加算の獲得・継続に影響を及ぼす因子の解析.
(第57回日本薬学会関東支部大会 2013)
中国医薬品市場の現状と製薬企業の動向分析および今後の展開.
(第57回日本薬学会関東支部大会 2013)
P2X4 receptor-mediated acceleration of microglial activation is important for the L-glutamate release from activated microglia in the early stage of inflammation.
(Neuro2013 2013)

※　J-GLOBALの研究者情報は、researchmapの登録情報に基づき表示しています。登録・更新については、こちらをご覧ください。

鈴木 岳之